Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

active_not_recruiting120%
completed480%

Recent Activity

1 active trials
Showing 5 of 5
completednot_applicable

Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)

NCT05591989
active_not_recruitingnot_applicable

NEUROMARK Registry Study

NCT05937308
completednot_applicable

NEUROMARK Randomized Controlled Trial

NCT06128200
completednot_applicable

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

NCT05324397
completednot_applicable

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

NCT04769596

Clinical Trials (5)

Showing 5 of 5 trials
NCT05591989Not Applicable

Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)

Completed
NCT05937308Not Applicable

NEUROMARK Registry Study

Active Not Recruiting
NCT06128200Not Applicable

NEUROMARK Randomized Controlled Trial

Completed
NCT05324397Not Applicable

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

Completed
NCT04769596Not Applicable

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5